Outcome of Therapy-Related Acute Promyelocytic Leukemia With or Without Arsenic Trioxide as a Component of Frontline Therapy

BACKGROUND: Patients with therapy-related acute promyelocytic leukemia (t-APL) have been commonly exposed to topoisomerase inhibitors and may potentially benefit from induction regimens omitting anthracyclines. METHODS: Retrospective analysis of the outcomes of 29 patients with t-APL who were either...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Dayyani, Farshid, Kantarjian, Hagop, O’Brien, Susan, Pierce, Sherry, Jones, Dan, Faderl, Stefan, Garcia-Manero, Guillermo, Cortes, Jorge, Ravandi, Farhad
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287232/
https://ncbi.nlm.nih.gov/pubmed/20803607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25585
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares